19 July 2019 - Deborah Wilkes
Archived
Johnson & Johnson's (J&J's) OTC sales in the US increased by 6.6% to USD484 million in the second quarter of 2019, following the acquisition of natural health specialist Zarbee's.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.